| Literature DB >> 34814910 |
Shishir Ram Shetty1, Saad Wahby Al Bayatti2, Natheer Hashim Al-Rawi2, Vinayak Kamath3, Sesha Reddy4, Sangeetha Narasimhan2, Sausan Al Kawas2, Medhini Madi5, Sonika Achalli6, Supriya Bhat6.
Abstract
INTRODUCTION: Nasal septal deviation (NSD) and concha bullosa (CB) are associated with airway obstruction in mouth breathers. Mouth breathing is associated with alterations in maxillary growth and palatal architecture. The aim of our study was to determine the effect of the presence of CB and NSD on the dimensions of the hard palate using cone-beam computed tomography (CBCT).Entities:
Keywords: Concha bullosa; Cone beam computed tomography; Nasal septum; Palate; Turbinate
Mesh:
Year: 2021 PMID: 34814910 PMCID: PMC8609805 DOI: 10.1186/s12903-021-01974-6
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Fig. 1Coronal CBCT section showing the landmarks used for measuring the SDA. The thickening of the sinonasal mucosa was also observed in this image
Fig. 2Coronal CBCT section showing landmarks for the palatal dimension measurements. The palatal interalveolar length (PIL) is the distance between the mid-centres of the cervical portion of the available tooth, from one side to the other. If there was no tooth, then the mid-centre of the alveolar bone near the crest was considered the reference point. Palatal arch depth (PAD) is the length of the line from "P" (junction of the nasal septum and hard palate) to the interalveolar line. The maxillopalatal arch angle (MPAA) is the angle that is formed by the lines from "P" to both points of the mid-centre of the available tooth or the midpoint maxillary alveolar bone for patients missing teeth
Fig. 3Coronal CBCT view showing the method used for identifying CB as per the criteria by Stallman et al. Line E1E2 represents the vertical length of the middle turbinate. Line F1F2 represents the extent of pneumatization caused by CB
Comparison of the gender distribution of the subjects in the study groups
| Group | Total | Chi-square test | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | Chi square value | ||
| Male | ||||||
| 60 | 35 | 18 | 13 | 126 | 1.67 | 0.65 (NS) |
| 66.66% | 63.63% | 56.25% | 56.52% | 63% | ||
| Female | ||||||
| 30 | 20 | 14 | 10 | 74 | ||
| 33.33% | 36.37% | 43.75% | 43.48% | 37% | ||
Showing the overall comparison of the age, SDA, PIL, PD, and MPAA among the four study groups
| Study groups | N | Mean | SD | Min | Max | ANOVA | |
|---|---|---|---|---|---|---|---|
| F | |||||||
| 1 | 90 | 51.88 | 14.58 | 27 | 80 | 3.42 | 0.65 (NS) |
| 2 | 55 | 49.98 | 14.65 | 20 | 70 | ||
| 3 | 32 | 49.17 | 15.63 | 18 | 72 | ||
| 4 | 23 | 51.4 | 14.82 | 27 | 80 | ||
| 1 | 90 | 0 | 0 | 0 | 0 | 226.27 | < 0.001* |
| 2 | 55 | 7.6 | 3.41 | 2 | 14 | ||
| 3 | 32 | 0 | 0 | 0 | 0 | ||
| 4 | 23 | 12.86 | 4.73 | 3 | 21 | ||
| 1 | 90 | 44.21 | 4.23 | 37.33 | 55.15 | 79.00 | < 0.001* |
| 2 | 55 | 39.81 | 1.93 | 36.06 | 44.15 | ||
| 3 | 32 | 40.37 | 1.92 | 36.16 | 44.09 | ||
| 4 | 23 | 35.91 | 1.87 | 33.03 | 40.22 | ||
| 1 | 90 | 13.16 | 1.18 | 10.55 | 15.35 | 51.12 | < 0.001* |
| 2 | 55 | 14.90 | 1.58 | 10.48 | 16.93 | ||
| 3 | 32 | 15.47 | 2.48 | 6.84 | 21.55 | ||
| 4 | 23 | 17.35 | 1.26 | 14.02 | 20.45 | ||
| 1 | 90 | 123.67 | 3.62 | 117.50 | 131.20 | 48.18 | < 0.001* |
| 2 | 55 | 119.73 | 2.26 | 116.00 | 124.00 | ||
| 3 | 32 | 120.62 | 2.39 | 116.00 | 126.00 | ||
| 4 | 23 | 116.81 | 2.94 | 110.00 | 123.10 | ||
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Post hoc tests for intergroup comparison age, SDA, PIL, PD, and MPAA among the four study groups
| Dependent variable | (I) Group | (J) Group | Mean difference (I–J) | Std. error | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||
| Age | 1 | 2 | 2.90 | 2.94 | 1.00(NS) | − 4.29 | 10.51 |
| 3 | 2.71 | 2.94 | 0.79(NS) | − 4.90 | 10.32 | ||
| 4 | 2.48 | 2.91 | 1.00(NS) | − 7.06 | 8.01 | ||
| 2 | 3 | 2.19 | 2.95 | 0.85(NS) | − 7.84 | 7.54 | |
| 4 | 2.42 | 2.92 | 1.00(NS) | − 6.00 | 8.85 | ||
| 3 | 4 | 2.23 | 2.92 | 0.87(NS) | − 9.81 | 5.34 | |
| SDA | 1 | 2 | − 7.60 | 0.60 | < 0.001* | − 9.15 | − 6.06 |
| 3 | 0 | 0.595 | 1.00(NS) | − 1.54 | 1.54 | ||
| 4 | − 12.86 | 0.59 | < 0.001* | − 14.39 | − 11.33 | ||
| 2 | 3 | 7.60 | 0.60 | < 0.001* | 6.05 | 9.16 | |
| 4 | − 5.26 | 0.59 | < 0.001* | − 6.79 | − 3.72 | ||
| 3 | 4 | − 12.86 | 0.59 | < 0.001* | − 14.40 | − 11.32 | |
| Palatal intralveolar length | 1 | 2 | 4.40 | 0.55 | < 0.001* | 2.98 | 5.81 |
| 3 | 3.84 | 0.55 | < 0.001* | 2.43 | 5.25 | ||
| 4 | 8.29 | 0.54 | < 0.001* | 6.89 | 9.69 | ||
| 2 | 3 | − 0.56 | 0.55 | 0.74(NS) | − 1.98 | 0.86 | |
| 4 | 3.90 | 0.54 | < 0.001* | 2.49 | 5.30 | ||
| 3 | 4 | 4.45 | 0.54 | < 0.001* | 3.05 | 5.86 | |
| Palatal depth | 1 | 2 | − 1.75 | 0.35 | < 0.001* | − 2.64 | − 0.85 |
| 3 | − 2.31 | 0.35 | < 0.001* | − 3.21 | − 1.42 | ||
| 4 | − 4.19 | 0.34 | < 0.001* | − 5.08 | − 3.31 | ||
| 2 | 3 | − 0.57 | 0.35 | 0.37(NS) | − 1.46 | 0.33 | |
| 4 | − 2.45 | 0.34 | < 0.001* | − 3.34 | − 1.56 | ||
| 3 | 4 | − 1.88 | 0.34 | < 0.001* | − 2.77 | − 0.99 | |
| Mid palatal arch angle | 1 | 2 | 3.94 | 0.58 | < 0.001* | 2.43 | 5.44 |
| 3 | 3.05 | 0.58 | < 0.001* | 1.54 | 4.55 | ||
| 4 | 6.85 | 0.57 | < 0.001* | 5.36 | 8.34 | ||
| 2 | 3 | − 0.89 | 0.58 | 0.42(NS) | − 2.40 | 0.62 | |
| 4 | 2.92 | 0.58 | < 0.001* | 1.42 | 4.41 | ||
| 3 | 4 | 3.81 | 0.58 | < 0.001* | 2.31 | 5.30 | |
Tukey post hoc test
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Overall comparison of the PIL, PD, and PAA in study subjects with unilateral CB, bilateral CB and absence of CB
| CB | N | Mean | SD | Min | Max | ANOVA | |
|---|---|---|---|---|---|---|---|
| F | |||||||
| Absent | 145 | 42.03 | 3.96 | 36.06 | 55.15 | 31.27 | < 0.001* |
| Unilateral | 40 | 38.17 | 2.82 | 33.06 | 44.09 | ||
| Bilateral | 15 | 37.68 | 3.50 | 33.03 | 42.63 | ||
| Absent | 145 | 14.02 | 1.64 | 10.48 | 16.93 | 39.50 | < 0.001* |
| Unilateral | 40 | 16.31 | 2.27 | 6.84 | 21.55 | ||
| Bilateral | 15 | 17.06 | 1.39 | 14.25 | 19.44 | ||
| Absent | 145 | 121.72 | 3.60 | 116.00 | 131.20 | 19.41 | < 0.001* |
| Unilateral | 40 | 118.83 | 3.21 | 110.00 | 126.00 | ||
| Bilateral | 15 | 117.93 | 3.66 | 111.30 | 123.00 | ||
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Post hoc analysis of the SDA, PIL, PD and PAA in study subjects with unilateral CB, bilateral CB and absence of CB
| Dependent variable | (I) CB | (J) CB | Mean difference (I–J) | Std. error | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||
| PIL | Absent | Unilateral | 3.86 | 0.52 | < 0.001* | 2.62 | 5.09 |
| Bilateral | 4.35 | 0.94 | < 0.001* | 2.13 | 6.57 | ||
| Unilateral | Bilateral | 0.49 | 0.95 | 0.86(NS) | − 1.76 | 2.74 | |
| PD | Absent | Unilateral | − 2.28 | 0.29 | < 0.001* | − 2.96 | − 1.61 |
| Bilateral | − 3.04 | 0.52 | < 0.001* | − 4.26 | − 1.82 | ||
| Unilateral | Bilateral | − 0.75 | 0.52 | 0.32(NS) | − 1.99 | 0.48 | |
| MPAA | Absent | Unilateral | 2.89 | 0.52 | < 0.001* | 1.67 | 4.11 |
| Bilateral | 3.79 | 0.93 | < 0.001* | 1.60 | 5.99 | ||
| Unilateral | Bilateral | 0.90 | 0.94 | 0.61(NS) | − 1.33 | 3.13 | |
Tukey post hoc test
*p < 0.05 statistically significant; p > 0.05 Non significant, NS
Overall comparison of the PIL, PD, and MPAA in study subjects with unilateral TH, bilateral TH and absence of TH
| Turbinate hypertrophy | N | Mean | SD | Min | Max | ANOVA | |
|---|---|---|---|---|---|---|---|
| F | |||||||
| Absent | 127 | 41.69 | 4.28 | 33.45 | 55.15 | 12.94 | < 0.001* |
| Unilateral | 60 | 38.96 | 3.34 | 33.03 | 49.04 | ||
| Bilateral | 15 | 38.16 | 3.75 | 34.02 | 42.63 | ||
| Absent | 127 | 14.24 | 1.86 | 10.55 | 18.76 | 15.10 | < 0.001* |
| Unilateral | 60 | 15.89 | 2.27 | 6.84 | 21.55 | ||
| Bilateral | 15 | 16.36 | 2.52 | 12.50 | 19.44 | ||
| Absent | 127 | 121.25 | 4.00 | 110.00 | 131.20 | 5.73 | 0.004* |
| Unilateral | 60 | 119.43 | 3.48 | 110.00 | 129.30 | ||
| Bilateral | 15 | 119.86 | 2.31 | 116.00 | 123.00 | ||
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Post hoc analysis of the SDA, PIL, PD, and MPAA in study subjects with unilateral TH, bilateral TH and absence of TH
| Dependent variable | (I) Turbinate hypertrophy | (J) Turbinate hypertrophy | Mean difference (I–J) | Std. error | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||
| PIL | Absent | Unilateral | 2.72 | 0.56 | < 0.001* | 1.41 | 4.04 |
| Bilateral | 3.52 | 1.48 | 0.04* | 0.02 | 7.03 | ||
| Unilateral | Bilateral | 0.80 | 1.47 | 0.85(NS) | − 2.67 | 4.27 | |
| PD | Absent | Unilateral | − 1.66 | 0.31 | < 0.001* | − 2.39 | − 0.92 |
| Bilateral | − 2.12 | 0.83 | 0.03* | − 4.09 | − 0.15 | ||
| Unilateral | Bilateral | − 0.47 | 0.83 | 0.84(NS) | − 2.42 | 1.48 | |
| MPAA | Absent | Unilateral | 1.83 | 0.54 | 0.003* | 0.55 | 3.11 |
| Bilateral | 1.40 | 1.45 | 0.60(NS) | − 2.02 | 4.82 | ||
| Unilateral | Bilateral | − 0.43 | 1.43 | 0.95(NS) | − 3.82 | 2.95 | |
Tukey post hoc test
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Multiple linear regression to predict PIL, PD, and MPAA based on the study variables
| Model | Unstandardized coefficients | Standardized coefficients | t | 95.0% CI for B | ||||
|---|---|---|---|---|---|---|---|---|
| B | Std. error | Beta | Lower bound | Upper bound | ||||
| PIL | (Constant) | 43.24 | 0.92 | 46.85 | < 0.001* | 41.42 | 45.06 | |
| Age | 0.01 | 0.01 | 0.04 | 0.79 | 0.43 (NS) | − 0.02 | 0.04 | |
| Gender | − 0.49 | 0.43 | − 0.06 | − 1.15 | 0.25 (NS) | − 1.34 | 0.35 | |
| SDA | − 0.37 | 0.03 | − 0.58 | − 10.98 | < 0.001* | − 0.44 | − 0.31 | |
| CB | − 2.30 | 0.39 | − 0.37 | − 5.90 | < 0.001* | − 3.07 | − 1.53 | |
| TH | 0.38 | 0.46 | 0.05 | 0.83 | 0.04* | − 2.52 | − 1.28 | |
| PD | (Constant) | 14.53 | 0.60 | 24.42 | < 0.001* | 13.36 | 15.71 | |
| Age | − 0.02 | 0.01 | − 0.10 | − 1.78 | 0.08 (NS) | − 0.03 | 0.00 | |
| Gender | − 0.10 | 0.28 | − 0.02 | − 0.35 | 0.73 (NS) | − 0.64 | 0.45 | |
| SDA | 0.12 | 0.02 | 0.34 | 5.68 | < 0.001* | 0.08 | 0.17 | |
| CB | 1.65 | 0.25 | 0.47 | 6.56 | < 0.001* | 1.15 | 2.15 | |
| TH | 0.08 | 0.30 | 0.12 | 0.28 | 0.03* | 1.67 | 2.50 | |
| MPAA | (Constant) | 122.80 | 0.96 | 128.35 | < 0.001* | 120.91 | 124.68 | |
| Age | 0.01 | 0.01 | 0.03 | 0.50 | 0.62 (NS) | − 0.02 | 0.03 | |
| Gender | − 0.49 | 0.45 | − 0.06 | − 1.09 | 0.28 (NS) | − 1.36 | 0.39 | |
| SDA | − 0.33 | 0.04 | − 0.55 | − 9.44 | < 0.001* | − 0.40 | − 0.26 | |
| CB | − 2.19 | 0.41 | − 0.37 | − 5.41 | < 0.001* | − 2.99 | − 1.39 | |
| TH | 1.12 | 0.47 | 0.16 | 2.35 | 0.02* | 0.18 | 2.05 | |
Mid palatal intralveolar length—F(5, 189) = 42.87, p < 0.001, R2 = 0.53. Palatal depth F(5, 189) = 24.75, p < 0.001, R2 = 0.40. Palatal arch angle F(5, 189) = 28.87, p < 0.001, R2 = 0.43.
*p < 0.05 statistically significant, p > 0.05 Non significant, NS
Correlation between PIL, PD, MPAA and SDA
| PIL | PD | MPAA | ||
|---|---|---|---|---|
| Group 2 | r | − 0.28 | 0.02 | − 0.21 |
| 0.051 (NS) | 0.92 (NS) | 0.15 (NS) | ||
| Group 4 | r | − 0.66 | 0.67 | − 0.63 |
| < 0.001* | 0.01* | 0.02* | ||
Pearsons’ correlation test
*p < 0.05 statistically significant, p > 0.05 Non significant, NS